
AstraZeneca’s immunotherapy drug Imfinzi has won a long waiting approval from the U.S. Food and Drug Administration (FDA) for use in lung cancer. The approval […] Read More
AstraZeneca’s immunotherapy drug Imfinzi has won a long waiting approval from the U.S. Food and Drug Administration (FDA) for use in lung cancer. The approval […] Read More